SUMMARY A survey of blood lead concentrations is reported in a group of 199 young Walsall children (3-6 years of age). The geometric mean blood lead concentration was 047 iimoll (range 0-2-1-6 smol/l). There were no significant differences in blood lead concentrations between groups of children with different ages, sex, ethnic origin, or environment.
Environmental lead pollution is widely regarded as a risk to child health. Raised blood lead concentrations in children, however, can be due to many causes including airborne lead, lead in soil, lead in household dust, pica, finger sucking, lead in food and water supplies, and lead in oriental cosmetics (for example, surma) .
Walsall is an industrial borough with established atmospheric and soil lead pollution. Earlier surveys carried out in Birmingham reported that many inner city children (particularly of the ethnic Asian minority) had raised blood lead concentrations (>1.69 Rmol/l). ' 2 The main objective of the present collaborative study was to carry out a pilot survey of blood lead concentrations in young WaIsall children and to assess factors that might be expected to influence blood lead concentrations-for example, age, sex, ethnic origin, location of home, diet, and social background.
Subjects and methods
The study population comprised 199 children randomly selected from the Walsall Child Health Register stratified by age, sex, ethnic state, and area of residence. Children aged 3-6 years were from three 'lead polluted' areas and one 'control' area of Walsall (table) . A questionnaire covering relevant social and environmental information was completed by a health visitor in the home, along with a hand wipe test for lead. A clinical examination for growth parameters and for signs of lead intoxication was carried out together with a venepuncture for blood lead, haemoglobin, and zinc protoporphyrin concentrations.
Blood lead concentrations were measured by atomic absorption spectrometry (Delves' cup). Particular attention was paid to ensuring good accuracy and precision.3 Measurement of hand lead was carried out with lead free moist tissues used for personal cleansing. Two other tests were selected as potential markers of chronic lead exposure-blood haemoglobin and erythrocyte zinc protoporphyrin.
Results
The frequency distribution of blood lead concentrations for the whole population ( figure) shows a distinct positive 'skew', consistent with a log-normal distribution. The geometric mean was 047 [tmol/l, with extreme values of 02 and 1-6 ,umol/l. There were no significant differences in blood lead concentrations for children living in the four geographic areas (table) . Moreover, age, sex, and ethnic origin did not significantly influence blood lead concentrations. Only five children from the ethnic minority used surma eye make up and this factor did not significantly influence blood lead concentrations. Each interval corresponds to 0 I ,umolll. Measurement of erythrocyte zinc protoporphyrin in 199 children showed no correlation with blood lead concentrations (r=0.02). Moreover, there were no significant differences in erythrocyte zinc protoporphyrin concentrations in children from the four study areas (table) . The only positive finding was an association between raised erythrocyte zinc protoporphyrin concentrations and significant iron deficiency anaemia.
The geometric mean blood haemoglobin concentration was 125 g/l, with extreme values of 80 and 170 g/l. Eighteen children (9%) had haemoglobin concentrations less than 110 g/l and were regarded as being anaemic. There was no significant correlation between haemoglobin and blood lead concentrations (r=0.10). There were also no significant differences in mean haemoglobin concentrations for children living in the four study areas (table) . There was, however, a highly significant negative correlation (r=-0-65, p<0-01) between blood haemoglobin and erythrocyte zinc protoporphyrin concentrations. The plasma ferritin concentrations in children ,with anaemia were all less than 10 tsg/l (normal range 15-140 [tg/l) We express our appreciation to the families of Walsall and their general practitioners, who allowed us to study the children, and to the health visitors based at Walsall Manor Hospital who carried out the field work for the survey. We also thank staff of the department of clinical chemistry, Walsall Manor Hospital and the departmcnt of haematology, Dudley Road Hospital, Birmingham for carrying out additional investigations.
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Sublingual nifedipine in acute severe hypertension J H C EVANS, N J SHAW, AND J T BROCKLEBANK Department of Paediatrics and Child Health, St James's University Hospital, Leeds SUMMARY Sublingual nifedipine was used for the treatment of acute severe hypertension in 12 children with renal disease. An average dose of 0-24 mg/kg was safe and proved effective on most occasions within 30 minutes with a median duration of action of three hours. There were no major adverse effects.
The current recommendations for the treatment of hypertensive crises in children advocate the use of intravenous infusions of labetalol or sodium nitroprusside.1 Administration of these drugs has the disadvantage that they require parenteral administration and nitroprusside has to be protected from light to prevent decomposition. A drug that could be given orally that would act rapidly but would not cause profound hypotension would be an advantage. Nifedipine administered sublingually has been shown to be a safe and effective means of lowering blood pressure in adults.2 3 Its advantages are the ease of administration, absence of serious side effects, and the fact that it has been shown to increase cerebral blood flow thus reducing the risk of cerebral ischaemia. 2 Over an 18 month period from February 1986 we have collected data on the use of nifedipine on 35 occasions in 12 children with severe hypertension.
Patients and methods
The 12 children with known renal disorders were all studied while inpatients (table 1) . Their ages ranged from 6-15 years and weights from 16-60 kg. Eleven of the children were being treated with other antihypertensive drugs. Each child had an acute rise in blood pressure recorded on at least two occasions before treatment and needed urgent treatment. In each case the diastolic blood pressure was equal to or greater than 110 mm Hg. Children with features of hypertensive encephalopathy were not studied. Children below 30 kg body weight were given 5 mg nifedipine and children weighing 30 kg or more 10 mg. The dose range was 0*18 to 0-32 mg/kg with a mean dose of 0-24 mg/kg. The capsule was administered either by being cracked between the teeth and held under the tongue or by initially piercing the capsule with a needle and squeezing the contents out under the tongue. The blood pressure and pulse were measured before treatment, at 15 and 30 minutes, and then hourly for six hours. The blood pressure was measured with the child lying down by either one observer using a sphygmomanometer and an appropriate sized cuff covering at least two thirds of the upper arm, or an automated oscillometric device (Dinamap) when more than one observer monitored the blood pressure.
During the study period all other antihypertensive lead exposure.
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